Tci Wealth Advisors, Inc. Atri Cure, Inc. Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$35.87 - $47.22 $3,766 - $4,958	105 Added 10500.0%	106 $4,000
Q4 2022 Feb 06, 2023	SELL	$33.48 - $47.45 $3,281 - $4,650	-98 Reduced 98.99%	1 $0
Q3 2022 Nov 08, 2022	BUY	$38.25 - $52.62 $38 - $52	1 Added 1.02%	99 $4,000
Q2 2022 Jul 19, 2022	BUY	$35.1 - $66.01 $3,439 - $6,468	98 New	98 $4,000
Q1 2022 Apr 29, 2022	SELL	$57.43 - $71.39 $5,111 - $6,353	-89 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$63.4 - $87.14 $126 - $174	2 Added 2.3%	89 $6,000
Q2 2021 Aug 02, 2021	BUY	$64.13 - $80.18 $3,527 - $4,409	55 Added 171.88%	87 $7,000
Q1 2021 Apr 29, 2021	BUY	$53.79 - $66.98 $1,721 - $2,143	32 New	32 $2,000

212

49.6M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.85B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.